Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 710 (USA) (Dr. Silva)
· consented 2013-07-22
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
severe
assessed
2026-08-18
Severe MYOCARDIAL INFARCTION — outcome: FATAL; onset 2013-08-02 (study day 12.0); relationship: POSSIBLE; serious criteria: hospitalization, death, life-threatening
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.